In conclusion, our results suggest that SHMT2 inhibits CD8T cell infiltration and induces immune escape by regulating the MIF/CD44 signaling axis, which in turn promotes HNSCC progression. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.